Richard Vincent | Chief Financial Officer |
James Breitmeyer | President and Chief Executive Officer |
Frank Hsu | Chief Medical Officer |
Hartaj Singh | Oppenheimer & Company |
Kumar Raja | Brookline Capital Markets |
Greetings and welcome to the Oncternal Therapeutics Third Quarter Earnings and Business Update Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Richard Vincent, CFO.